New Mathematical Model Reveals Drug-Specific Effects in Lab-Grown Human Muscle Tissue
Researchers developed a human engineered skeletal muscle platform combined with a stretched exponential mathematical model to capture detailed contraction kinetics during pharmacological testing. The system uses the LHCN-M2 human cell line to grow aligned, multinucleated muscle fibers within 14 days, avoiding the variability of primary cells or the limited relevance of mouse models. The approach could improve drug screening by revealing kinetic signatures that standard peak-force measurements miss.
A study posted to bioRxiv describes a scalable platform for generating engineered skeletal muscle tissues (ESMs) from the human LHCN-M2 cell line, which mature into functional myofibers expressing key sarcomeric markers within 14 days. To analyze contraction dynamics, the team introduced a mathematical framework based on stretched exponential functions that characterizes both contraction and relaxation phases using six interpretable parameters. When tested against a library of standard pharmacological modulators, the model identified distinct kinetic 'fingerprints' for different drug classes — information that conventional peak-force analysis failed to capture. Proteomic profiling was also used to confirm the presence of relevant drug targets and assess the maturation state of the tissues. The authors argue the platform addresses two longstanding problems in the field: high variability associated with primary human cells and the limited translational relevance of murine muscle lines. The combined experimental and modeling approach is presented as a high-content screening tool applicable to drug development, disease modeling, and fundamental muscle biophysics.
What's missing
As a preprint, this work has not yet undergone peer review, so the validity of the stretched exponential model and the reproducibility of the ESM platform remain to be independently assessed. The study does not report direct comparison of the LHCN-M2-based ESMs against primary human muscle tissue to quantify how closely the model recapitulates in vivo physiology. Long-term stability of the tissues beyond 14 days and performance under disease-relevant conditions are not addressed.
What different sources said
- bioRxivCenter
Stretched Exponential Modeling Reveals Drug-Specific Kinetics in Human Engineered Skeletal Muscle
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.